The 2nd Symposium on Biochemical Drug Innovation and Development

The 'Second Symposium on Biochemical Drug Innovation and Development' sponsored by China Biochemical Pharmaceutical Industry Association and the second academician public welfare lecture hall of the National Pharmacopoeia Commission were successfully held in Hebei Zhangzhou International Conference Center.

The speakers of the seminar invited dozens of experts such as Academician Wang Guangji of the Chinese Academy of Engineering and Academician Shen Beifen of the Military Medical Research Institute, and attracted more than 500 experts and scholars, pharmaceutical industry researchers and pharmaceutical companies from all over the country to participate. The main contents of the seminar include policy development trend, quality standard improvement, production management compliance, original and auxiliary package related approval, interpretation of the listing permit holder system, consistency evaluation and re-evaluation. Through this activity, the government management department was promoted. The industry's authoritative experts and peer companies' dialogue and information sharing, while providing biochemical companies with a platform for communication and learning.

The China Biochemical Pharmaceutical Industry Association was commissioned by the former State Food and Drug Administration's Pharmacology Supervision Department to organize relevant experts and related enterprises to draft the “Biochemical GMP Appendices”, which was promulgated on March 16, 2017 and implemented on September 1. At the summit seminar, China Biochemical Pharmaceutical Industry Association issued a certificate to the drafting experts of the “Biochemical GMP Appendices” and the drafting units, and Zhejiang Huaduan Pharmaceutical Group as the drafting unit, and obtained the “Biochemical GMP Appendix to participate in the drafting unit”. certificate.